alle aandoening waarmee patiënten zich presenteren op de SEH voor de afdeling interne geneeskunde en maag- darm- en leverziekten n.v.t.
Conditions
Interventions
None listed
Sponsors
Zuyderland Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - >=65 years of age - Presentation to the emergency department (ED) for internal medicine or gastroenterology - Informed consent
Exclusion criteria
Exclusion criteria: - Earlier participation in study - No informed consent;Patients who want to participate in the study but refuse an arterial puncture can still participate in the study and are not excluded. We want to include these patients because we can still use other information for the primary objective and remaining secondary objectives.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of risk factors associated with an adverse outcome in elderly patients (>=65 years of age) who visit the internist/gastroenterologist at the ED. * Study parameters: Patient* characteristics, comorbidity, functional state, cognitive state, demographic parameters, number of previous visits to the hospital in the preceding year, use of medication, vital signs, number of doctor consultations during the stay in the ED, time spent in the ED, number of radiological examinations during ED consultation and diagnosis at admission or discharge from the ED. *Primary composite endpoint: - Mortality within 30 days of presentation to the ED - Readmissions within 30 days after discharge *Secondary endpoints: 1. Secondary composite endpoint: length of hospital stay (LOS), ICU/MCU admission, mortality within 30 days after presentation to the ED, readmission within 30 days after discharge from the hospital and discharge to another residence than previous address (nursing home/hospice) 2. Length of hospital stay (LOS) 3. ICU/MCU admission 4. Mortality within 30 days after presentation to the ED 5. Readmission within 30 days after discharge from the hospital 6. Discharge to another residence than previous address (nursing home/hospice) A list of data we will register for all patients who are admitted to the hospital or discharged from the ED can be found in the appendix. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Discriminating power of triage and risk stratification scores *Study parameters: MTS, APACHE II, ISAR-HP, abbMEDS, CURB-65, SOFA, GBS *Endpoints: the above-mentioned primary and secondary endpoints 2. Predictive value of the clinical impression (gut feeling) and disease perception *Study parameters: questionnaire of clinical impression by the doctor/nurse, disease perception by the patient/companion and the surprise question *Endpoints: the above-mentioned primary and secondary endpoints 3. Predictive value of laboratory tests *Study parameters: routine laboratory tests and biomarkers (lactate, hs-TnT, NT-pro-BNP, PCT and d-dimer) *Endpoints: the above-mentioned primary and secondary endpoints | — |
Countries
Netherlands
Outcome results
None listed